Next Article in Journal
Early Breast Milk Volumes and Response to Galactogogue Treatment
Next Article in Special Issue
Prevalence of High Blood Pressure in Pediatric Patients with Sleep-Disordered Breathing, Reversibility after Treatment: The KIDS TRIAL Study Protocol
Previous Article in Journal / Special Issue
Spontaneous Pneumomediastinum in Children with Viral Infections: Report of Three Cases Related to Rhinovirus or Respiratory Syncytial Virus Infection
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

PICU Survivorship: Factors Affecting Feasibility and Cohort Retention in a Long-Term Outcomes Study

1
Section of Developmental and Behavioral Pediatrics, Department of Pediatrics, The University of Chicago, 950 East 61st Street, Suite 207, Chicago, IL 60637, USA
2
Department of Pediatrics, Boston Children’s Hospital, Boston, MA 02115, USA
3
Department of Biostatistics & Medical Informatics, The University of Wisconsin-Madison, Madison, WI 53705, USA
4
Division of Critical Care Medicine, Department of Anesthesiology and Critical Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
*
Author to whom correspondence should be addressed.
Submission received: 26 April 2022 / Revised: 8 July 2022 / Accepted: 11 July 2022 / Published: 13 July 2022
(This article belongs to the Special Issue Pediatric Intensive Care – Practice and Research)

Abstract

:
Our understanding of longitudinal outcomes of Pediatric Intensive Care Unit (PICU) survivors is limited by the heterogeneity of follow-up intervals, populations, and outcomes assessed. We sought to demonstrate (1) the feasibility of longitudinal multidimensional outcome assessment and (2) methods to promote cohort retention. The objective of this presented study was to provide details of follow-up methodology in a PICU survivor cohort and not to present the outcomes at long-term follow-up for this cohort. We enrolled 152 children aged 0 to 17 years admitted to the PICU in a prospective longitudinal cohort study. We examined resource utilization, family impact of critical illness, and neurodevelopment using the PICU Outcomes Portfolio (POP) Survey which included a study-specific survey and validated tools: 1. Functional Status Scale, 2. Pediatric Evaluation of Disability Inventory Computer Adaptive Test, 3. Pediatric Quality of Life Inventory, 4. Strengths and Difficulties Questionnaire, and 5. Vanderbilt Assessment Scales for Attention Deficit-Hyperactivity Disorder. POP Survey completion rates were 89%, 78%, and 84% at 1, 3, and 6 months. Follow-up rates at 1, 2, and 3 years were 80%, 55%, and 43%. Implementing a longitudinal multidimensional outcome portfolio for PICU survivors is feasible within an urban, tertiary-care, academic hospital. Our attrition after one year demonstrates the long-term follow-up challenges in this population. Our findings inform ongoing efforts to implement core outcome sets after pediatric critical illness.

1. Introduction

Mortality in the pediatric intensive care unit (PICU) has decreased dramatically in recent decades, with a concomitant increase in morbidity, suggesting that mortality alone is no longer a sufficient metric of the long-term impact of critical illness [1,2,3,4,5,6]. The sequelae of critical illness are diverse; some children exhibit psychological difficulties as a result of traumatic experiences [7,8,9], while others experience cognitive [10,11,12] or physical [13] deficits. Post-intensive care syndrome in pediatrics (PICS-p) refers to this constellation of physical, cognitive, emotional, and social health problems facing PICU survivors and their families [14,15,16]. PICS-p also acknowledges that a child’s pre-illness baseline, including pre-existing neurodevelopmental disabilities [17] and other premorbid conditions, may also influence a child’s susceptibility to the impact of critical illness [18].
Our understanding of the extent of PICS-p is obscured by the variability in duration of follow-up, patient populations studied, and outcome measures. Importantly, PICU survivors do not have a medical home, distinguishing them from preterm infants or children with congenital heart disease who have dedicated follow-up clinics, potentially placing them at increased risk for loss to follow-up. Studies have assessed outcomes at discrete follow-up intervals [13,19,20,21,22,23], but few have followed children longitudinally. Other studies have been limited to follow-up of survivors with a specific subset of pathophysiology [24,25,26,27]. In a scoping review of pediatric critical care medicine literature from 1970–2017, over 360 unique instruments were used to evaluate long-term outcomes [28]. The heterogeneity of these findings limits our understanding of overall PICU survivorship, and in response, there has been increasing attention to the need to develop and implement core outcome sets [29,30,31] (i.e., standardized sets of outcomes to be measured and reported as a minimum in all effectiveness trials in a specific health area [32,33,34]). Ultimately, the widespread use of core outcome sets with standardized outcome measures will improve our understanding of PICS-p, allowing for greater comparability across studies.
However, prior to adaption, the factors governing feasibility of implementing core outcome sets must be considered. Among the 407 studies included in a recent scoping review of PICU long-term outcomes studies, enrollment in observational PICU survivorship studies varied from 61–100%, with even lower enrollment in qualitative studies ranging from 20–90% [28]. Retention at long-term follow-up was also highly variable, ranging from 68–100% [28]. In this prospective, longitudinal study piloting the use of multidimensional outcome measures to understand the frequency and natural history of PICS-p and to underscore the challenges associated with longitudinal follow-up among a heterogeneous group of children who experience critical illness, we also sought to measure changes in healthcare utilization and the familial and socioeconomic impact of critical illness and PICU survivorship. Here, we report our experience with regard to feasibility and cohort retention using a multidimensional outcome portfolio among PICU survivors through 3 years after hospital discharge.

2. Materials and Methods

Patients. Patients were enrolled specifically for this study from the PICU at Comer Children’s Hospital at the University of Chicago over 15 months (June 2017–August 2018) to account for the seasonal variation inherent in pediatric critical illness and injury. All children aged 0 to 17 years admitted to the PICU were eligible; parental presence at the bedside was necessary for consent and enrollment. No competing clinical or research follow-up programs were in existence at the time of study enrollment, and this cohort does not overlap with previously published cohorts of the authorship team [4,17,35,36]. Children were excluded if they were under state custody due to the logistical challenges of obtaining consent from the state for participation in a research study as well as potential flux in custodial situations at follow-up intervals. Non-English speakers were excluded because some instruments were only available in English with limited ability for translation during remote (telephone or e-mail) follow-up. Informed consent was obtained in person from parent(s)/guardians (hereafter, referred to as “parent(s)”), and assent was obtained from children aged 12 years or older. The protocol was approved by the Institutional Review Board at the University of Chicago.
Screening Process. The study team screened the PICU census for eligible patients and confirmed with the clinical team whether the parent could be approached for consent to participate (potentially denied or deferred due to patient acuity). The study team attempted to recruit several times throughout the hospital stay to capture parents. Bedside nurses facilitated opportunities for consent by notifying the study team when parents became available.
Measures—Enrollment. Measures were selected from existing validated surveys to capture a broad array of functional and neurodevelopmental outcomes. The study team assessed the Functional Status Scale (FSS) score, a validated measure using a five-point scale in each of six domains (mental, sensory, communication, motor, feeding, and respiratory status) from review of the electronic health record (EHR) or parent interview [37]. Parents completed the other survey instruments intended for caregiver informant report directly: 1. the Healthcare and Neurodevelopmental Profile and Family Impact Survey (Impact Survey), 2. The Pediatric Evaluation of Disability Inventory Computer Adaptive Test (PEDI-CAT), 3. the Pediatric Quality of Life Inventory (PedsQL), 4. the Strengths and Difficulties Questionnaire (SDQ), and 5. the National Institute for Children’s Health Quality Vanderbilt Assessment Scales (Vanderbilt). All survey instruments were administered sequentially in a single survey which comprised our PICU Outcomes Portfolio (POP) survey, except for the PEDI-CAT which was administered on an iPad or over the phone. Full details regarding the scoring of the validated instruments are available elsewhere [38,39,40,41].
The Impact Survey, designed by the study investigators, captures patients’ baseline health utilization and the family impact of the child’s illness. Items were cognitively tested with developmental and behavioral pediatric clinic patients prior to study initiation. The final survey length depended on an individual’s responses, but included about 30 questions. The Impact Survey includes modified questions from the National Survey of Children with Special Health Care Needs [42] regarding the child’s health (e.g., “What kind of place does your child go to when he/she is sick or you need advice about his/her health?”). In addition, questions capture the child’s access to and utilization of neurodevelopmental support services (e.g., “Does your child have an IEP (Individualized Educational Program)?”). Family impact is also assessed (e.g., “Has your child’s health conditions caused financial problems for your family?”). Supplementary Table S1.
The PEDI-CAT includes 15 items in each of four domains (daily activities, mobility, social/cognitive, and responsibility) to determine the degree of functioning in each category compared to same-aged peers. Adaptive testing maximizes information gathering while minimizing response burden [38].
The PedsQL is a multidimensional tool intended to quantify health-related quality of life in healthy and ill children up to 18 years of age. The PedsQL consists of 23 items in five domains (physical, psychosocial, emotional, social, and school) [39]. This measure was administered to all parents with versions tailored to the age range of the child: 1–12 months, 13–24 months, 2–4 years, 5–7 years, 8–12 years, or 13–18 years. The population mean for parent-proxy reported 81.3 and standard deviation 15.9 for healthy children [43].
The SDQ is a brief behavioral screening survey to assess pro-social behavior and psychopathology of children and adolescents aged 4–17 years [40]. Normative parent SDQ scores for U.S. children are 0–11 (for low difficulties, 12–15 for medium difficulties, and 16–40 for high difficulties [44].
The Vanderbilt is a tool that parallels signs and symptoms from DSM-IV to help healthcare professionals diagnose ADHD in children [41]. The Vanderbilt was administered to parents of children at least 5 years of age. Normative scores data for total Attention Deficit Hyperactivity Disorder (ADHD) score, ADHD inattentive, ADHD hyperactive, Oppositional Defiant Disorder (ODD), Conduct Disorder, and Anxiety/Depression are 3.4, 1.6, 1.8, 1.1, 0.5, and 0.4, respectively [45].
Data were collected and managed using the Research Electronic Data Capture (REDCap) tool [46]. Study staff administered all surveys and collected demographic information (name, age, and medical record number) on an iPad Pro (2017).
The EHR was reviewed for demographic characteristics, admission diagnosis, PICU length of stay, hospital length of stay, and vital signs. Clinical data elements were extracted from the Clinical Research Data Warehouse maintained by the Center for Research Informatics at the University of Chicago in order to calculate the severity of illness indices: Pediatric Risk of Mortality (PRISM) [47] and the Pediatric Sequential Organ Failure Assessment Score (pSOFA) [36] scores.
Measures—Discharge. FSS at hospital discharge was again determined from review of the EHR and/or direct interview with the patient’s PICU physicians or nurses.
Measures—Follow-up. Parents were contacted either via telephone or e-mail, per stated preference and contact information (1–2 telephone numbers [home and mobile] and an e-mail address) provided at the time of enrollment. No public or private data searches were conducted to obtain contact information. The child’s EHR was queried prior to contact to verify that the parent’s telephone number or e-mail had not changed and to ensure that the child had not died in the interval since last contact.
During any specific data-collection period, the study team determined, a priori, that 5 telephone calls within 1 month were reasonable and not intrusive. Parents were contacted at subsequent follow-up intervals even if they had not completed follow-up from the preceding interval. Parents received a 20 USD gift card for each completed follow-up, with a total potential incentive of 80 USD throughout the first year of follow-up and an additional 20 USD annually through to the 3-year follow-up.
A subset of the POP survey was completed at each follow-up interval to decrease overall response burden: 1 month (Impact Survey, SDQ), 3 months (Vanderbilt and PEDI-CAT), and 6 months (PedsQL and FSS). All components of the POP survey except for the PEDI-CAT were completed at 1 year after hospital discharge and annually through 3 years after discharge. Investigators anticipated that the time burden associated with reading the PEDI-CAT over the phone (typically self-administered by the participant using an iPad application) would deter participation, and thus re-administration of the PEDI-CAT was deferred until the 3-year follow-up.
Statistical Analyses. The objective of this presented study was to provide details of data acquisition and follow-up in a PICU survivor cohort and not to present the outcomes at long-term follow-up for this cohort. Descriptive statistics were used to characterize the demographic and clinical variables at each follow-up interval. Participant demographic characteristics were compared to the University of Chicago PICU population during the study period. Follow-up and feasibility data were collected and summarized using descriptive statistics. Analyses were performed using R, version 3.6 (R Project for Statistical Computing, Vienna, Austria), with two-sided p < 0.05 denoting statistical significance.

3. Results

3.1. Enrollment

A total of 832 hospitalized patients were screened for enrollment (Figure 1). There were 119 (14.3%) patients who did not meet the eligibility criteria. Of the 713 eligible children, a total of 496 patients were not approached: 228 (32%) due to lack of availability of parents at the bedside, 50 (7%) because the clinical team denied the study team the opportunity to approach parents for consent, and 218 (30.6%) were discharged prior to enrollment opportunity. Thus, of the 217 available parents, 70% (152 parents) provided consent to participate and were enrolled.

3.2. Cohort Characteristics

The University of Chicago Comer Children’s Hospital is an urban, academic, tertiary-care center that admits medical and surgical pediatric patients. Demographic and clinical characteristics of the study cohort are presented in Table 1. The median (range) age of the children was 5.2 (0–17) years, and 58.6% were male. Participants were 57.2% African American (n = 87), 33.6% Caucasian (n = 51), 9.2% “Other” (n = 14), and 9.2% Hispanic (n = 14). At the time of study enrollment, our typical patient population was 54.2% male, 59.8% African American, 26.7% White, and 24% surgical patients. Our overall PICU median length of stay was 2.9 days. Our study patients were similar to all patients admitted to the PICU during the study enrollment period with regard to sex, race, ethnicity, severity of illness, and length of stay. Study participants were older than the overall PICU population. (Supplementary Table S1).
Of the enrolled children, the three most common known admission diagnostic categories were pulmonary, surgical, and neurologic (39.5%, 21.7%, and 8.6%, respectively). The median (IQR) PICU length of stay was 3.0 (1.7–8.1) days, and the overall hospital length of stay was 4 (3–9) days. The mean admission pSOFA and PRISM scores were 4.6 (SD 2.4) and 9.2 (SD 4.5). Demographic and clinical characteristics did not vary between patients who did and did not complete follow-up at each time point.

3.3. Cohort Retention and Follow-Up

Of the total 152 patients enrolled, 132 parents (88.6%) completed the 1-month follow-up, 115 (77.7%) completed the 3-month follow-up, 123 (83.1%) completed the 6-month follow-up, and 117 (80.1%) completed the 1-year follow-up. (Figure 2) Of the 152 participants, 122 (80.3%) completed a follow-up for at least 3 of the 4 intervals during the first year of follow-up. At 2 years, 79 (54.5%) children completed the follow-up, and 56 (43.4%) completed the 3-year follow-up. Three patients died during the study follow-up, and four patients withdrew consent. Sixteen children were excluded from 3-year follow-up because they were ≥18 years of age and parents were no longer eligible to serve as informants.

3.4. Feasibility Factors

Parents provided their preferred contact method, most often the telephone. E-mail reminders were sent to parents who provided an e-mail address as an alternative contact method. While most parents did not complete their follow-up assessments via e-mail, e-mail correspondence enabled scheduling of telephone follow-ups at a convenient time for parents.
Among the parents who did not complete the follow-up, the median number of follow-up attempts were 6.5 (IQR 4–8) at 1 month, 5 (IQR 4–6) at 3 months, 6 (IQR 2–12) at 6 months, 11 (IQR 6–17.8) at 1 year, 5 (IQR 5–7) at 2 years, and 5 (IQR 5–6) at 3 years. Among the parents who completed the follow-up, the median number of follow-up attempts were 2 (IQR 1–4) at 1 month, 2 (IQR 1–3) at 3 months, 2 (IQR 1–3) at 6 months, 3 (IQR 2–6) at 1 year, 2 (IQR 1–4) at 2 years, and 4 (IQR 3–5) at 3 years. (Table 2). The majority of parents (89–97%) completed the follow-up during weekdays throughout the year. However, study staff attempted follow-ups on weekends with an additional 3–11% of parents. Parents were most often available during daytime hours (7:00 a.m.–4:59 p.m.) with 77–92% of parents completing follow-ups during these hours. Study staff successfully completed follow-ups in the evenings (5:00 p.m.–6:59 a.m.) for 8–24% of parents. The median number of days to completion of a follow-up survey ranged from 9–28 days. However, as many as 19.3% of parents completed their follow-up questions at a subsequent follow-up touchpoint (e.g., completed the 1-month survey at 3 months).
At least five follow-up attempts were made for most children at each interval; however, 13 children had fewer than three attempts documented at one of their follow-up intervals, which may be due to missed opportunities by our study team. With the exception of one child, all were recaptured at later time intervals. We also note that one child with an unusually prolonged hospitalization (>1 year) was inadvertently lost to follow-up because the child’s follow-up times did not coincide with the rest of the cohort.

4. Discussion

A longitudinal follow-up using a multidimensional PICU core-outcome portfolio is feasible for children and palatable to families discharged from the PICU. Our study has significant findings. Enrollment is the first and greatest hurdle. Consent rates among available families were favorable. Retention of this cohort of families for one year was high but there was notable attrition at 2 and 3 years. Our study demonstrates feasibility of implementing a core set of multidimensional outcomes that longitudinally assess the physical, cognitive, educational, social, emotional, behavioral, health-related quality of life, and family impact of pediatric critical illness in a heterogeneous patient population.
Enrollment of parents of PICU patients is challenging; most parents in our urban population were not available for consent and participation. Nearly one-third of eligible parents were not present throughout their child’s PICU hospitalization. The lack of parental presence is likely multifactorial due to lack of flexible employment schedules, caregiving responsibilities for other children, transportation barriers, and financial barriers (for food, parking, etc.). Another 30% of children were discharged prior to an approach by the study team, likely due to short stays or discharge at night or on weekends when the study team was not always available (reflecting the aforementioned logistical and socioeconomic challenges). A small percentage of families—7%—were not approached by the study team because of the care team’s concerns about suitability for a study focused on long-term outcomes due to the patient’s acuity and uncertain prognosis for survival.
While only 21% of all eligible families enrolled, the majority of families that were available to the study team agreed to participate. This high consent rate of 70% indicates a subgroup of patients that is willing to participate in studies of long-term follow-up. Our ability to enroll a smaller number of families compared to those who consented, reflecting loss to follow-up, may be explained in part by the demographic and social characteristics associated with risk of poor outcomes. For example, young caregiver age, caregiver language barriers, presence of social supports, transportation challenges, or caregiver intellectual disability are risk factors for adverse PICS-p outcomes [48]. These same factors may inhibit access to care, precluding participation in routine clinical or research-related follow-up.
Our data further reveal that maintenance of a cohesive cohort of 78–89% of these families of PICU survivors during the first year after hospital discharge was possible but necessitates strategic cohort-retention techniques with persistent contact attempts, incentives, flexible modalities, and attention to response burden. Our response rates were comparable to established rates of PICU follow-up at the 3-month follow-up interval. Notably, our response rates at the 1-month, 6-month, and 1-year intervals were more favorable than typical follow-up rates despite the lengthier response burden of the enrollment and 3-month instruments [4,23]. The higher response rates at these three intervals suggest that families were not deterred by the lengthier multidimensional surveys at the preceding intervals. Additionally, parents may have been most willing to participate 1 month after hospital discharge due to the proximity of their PICU experience as compared to subsequent follow-up intervals. Although parents remained highly responsive throughout the 1-year follow-up period, our response rates decreased at 2 and 3 years.
The reasons for our robust follow-up rates and ability to retain the study cohort through 1 year are likely multifactorial. Parents who completed follow-up typically required 2–3 contact attempts, with weekday and daytime hours yielding the highest follow-up rates. Having study staff also available intermittently on weekends and evenings did allow for greater overall cohort retention [49]; notably, the touchpoints during these times were generally brief and not overly burdensome for team members, but occasionally looped in otherwise difficult-to-reach parents. Additionally, our design included multiple attempts to contact parents based on their expressed preferred method of contact, allowed for flexibility regarding scheduling follow-up via telephone or e-mail, and attempted to recapture parents who were “lost to follow-up” at a previous interval. Gift cards for each participation interval may have been an important financial incentive for participation. The majority of parents completed three of the four follow-up assessments over the first year after discharge suggesting that our approach was effective.
Our attention to response burden may have also had a positive impact on our response rates. We informed parents upon enrollment that the outcomes survey was divvied into smaller aliquots except for annual follow-up to proactively manage expectations. We intentionally parsed the study instruments into different intervals to decrease response burden while creating a trajectory for each outcome metric (without a predesignated importance of obtaining certain instruments at specific time intervals). We asked parents to complete any previously missed follow-up instruments at the next follow-up interval, allowing for more complete data and recognizing that parents may differ in availability and willingness to participate.
Our low response rates at 2 and 3 years are not surprising and represent the challenges inherent to long-term remote follow-up. The ability to maintain a meaningful relationship or a relationship without a face-to-face connection is difficult. As more time ensues from PICU discharge to remote follow-up, parents may be less inclined to participate in an activity in which the patient or family does not receive a tangible health benefit (i.e., medical or neurodevelopmental evaluation or therapies). Financial incentive for participation may need to account for this attrition. Future efforts to increase retention rates in PICU follow-up programs would likely benefit from clinician and family education as well as care coordination; education regarding the importance of long-term follow-up and scheduling of these visits prior to discharge have yielded higher rates of neonatal follow-up clinic participation [50].
Our study had important limitations. Because our study design required in-person parent consent and completion of baseline study measures, only 21% of all eligible children were enrolled. We were not able to evaluate the demographic and clinical characteristics of children who did not enroll to understand if they were systematically different from our overall patient population. Our enrollment rates reflect the socioeconomic challenges (single-parent households, competing sibling care demands, inflexible work requirements, poverty, lack of transportation, etc.) that preclude regular parent presence at the bedside. Additionally, we excluded children who were wards of the state or whose parents were primarily non-English speakers due to logistical challenges related to changes in custody after discharge and coordination of interpreter services, parents, and study teams for telephone follow-up. Therefore, our findings may have limited generalizability and may not delineate the additional challenges presented by linguistic barriers. However, our study population was representative of our overall patient population with regard to demographic and clinical characteristics except for older age. Any resultant bias due to an older patient population is unclear, as our EHR does not contain data to determine neurodevelopmental vulnerability. Most parents reported that they had not answered a prior contact attempt because they were busy and did not describe feeling overwhelmed by touchpoints. Directly measuring time burden for parents would provide insight into potential barriers to study completion and inform future work. Semistructured interviews with families to assess the feasibility or perceived burden of participating in longitudinal follow-up studies would further inform efforts to increase recruitment and retention for PICU survivorship studies. Studies indicate that a sense of partnership and family-focused interventions are important facilitators for neonatal follow-up [51,52].
In this manuscript, we report details regarding follow-up methodology and did not present the outcomes at long-term follow-up. In the nascent field of PICU survivorship, providing a methodologic “roadmap” to conduct long-term outcome research is essential. This methodology serves as a starting point for investigators to address the feasibility challenges associated with follow-up studies in a heterogenous population without a common medical home. We did not present methodology and results as a single manuscript because publication page limits would necessitate an abbreviated focus on methodology without the level of detail we were able to provide here.

5. Conclusions

Our results suggest that a multidimensional longitudinal follow-up for a heterogeneous group of children who survive pediatric critical illness is feasible. We identified logistical and resource challenges with enrollment. Frequent attempts to connect with families with flexibility in scheduling remote follow-up, financial incentivization, and minimization of response burden are key elements for retaining a cohort of PICU survivors. Ultimately, understanding the multidimensional scope and trajectories of long-term outcomes facing PICU survivors will allow us to develop and implement interventions that will maximize quality of life and overall functioning for children who experience critical illness.

Supplementary Materials

The following supporting information can be downloaded at: https://0-www-mdpi-com.brum.beds.ac.uk/article/10.3390/children9071041/s1, Table S1: POP Impact Survey.

Author Contributions

S.A.S. and N.P.P. conceptualized the study, conducted analyses, interpreted results, drafted the manuscript, and orchestrated revision by all coauthors. A.V.D. and E.J.L. assisted with recruitment, data entry, and data analysis. A.M. conducted data analysis. All authors have read and agreed to the published version of the manuscript.

Funding

Sarah Sobotka received support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, K23 HD097276) and the T73 Leadership Education in Neurodevelopmental and Related Disorders Training Program (LEND, T73MC11047). Ayesha Dholakia received support from the University of Chicago Pritzker School of Medicine Summer Research Program and Scholarship and Discovery Program. Anoop Mayampurath received support from the National Heart, Lung, and Blood Institute (K01HL148390). Neethi Pinto received support from The Bucksbaum Institute for Clinical Excellence at The University of Chicago and The University of Chicago Comer Development Board.

Institutional Review Board Statement

The study was approved by the Institutional Review Board of The University of Chicago (protocol code IRB 17-0266 and 18 March 2017).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available.

Acknowledgments

We would like to thank study team members Allison Kniola, Maya Rhine, Maya Krasnow, Nicolas Charron, Khloe Pastore, and Nicole Howard for their contributions to patient recruitment and follow-up. Support for this study was provided by the Department of Pediatrics and the Bucksbaum Institute for Clinical Excellence at The University of Chicago.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Namachivayam, P.; Shann, F.; Shekerdemian, L.; Taylor, A.; van Sloten, I.; Delzoppo, C.; Daffey, C.; Butt, W. Three decades of pediatric intensive care: Who was admitted, what happened in intensive care, and what happened afterward. Pediatr. Crit. Care Med. 2010, 11, 549–555. [Google Scholar] [CrossRef]
  2. Aspesberro, F.; Mangione-Smith, R.; Zimmerman, J.J. Health-related quality of life following pediatric critical illness. Intensive Care Med. 2015, 41, 1235–1246. [Google Scholar] [CrossRef]
  3. Pollack, M.M.; Holubkov, R.; Funai, T.; Clark, A.; Berger, J.T.; Meert, K.; Newth, C.J.; Shanley, T.; Moler, F.; Carcillo, J.; et al. Pediatric intensive care outcomes: Development of new morbidities during pediatric critical care. Pediatr. Crit. Care Med. 2014, 15, 821–827. [Google Scholar] [CrossRef]
  4. Pinto, N.P.; Rhinesmith, E.W.; Kim, T.Y.; Ladner, P.H.; Pollack, M.M. Long-Term Function After Pediatric Critical Illness: Results From the Survivor Outcomes Study. Pediatr. Crit. Care Med. 2017, 18, e122–e130. [Google Scholar] [CrossRef]
  5. Taylor, A.; Butt, W.; Ciardulli, M. The functional outcome and quality of life of children after admission to an intensive care unit. Intensive Care Med. 2003, 29, 795–800. [Google Scholar] [CrossRef]
  6. Gemke, R.J.; Bonsel, G.J.; van Vught, A.J. Long-term survival and state of health after paediatric intensive care. Arch. Dis. Child. 1995, 73, 196–201. [Google Scholar] [CrossRef] [Green Version]
  7. Davydow, D.S.; Richardson, L.P.; Zatzick, D.F.; Katon, W.J. Psychiatric morbidity in pediatric critical illness survivors: A comprehensive review of the literature. Arch. Pediatr. Adolesc. Med. 2010, 164, 377–385. [Google Scholar] [CrossRef] [Green Version]
  8. Bronner, M.B.; Knoester, H.; Bos, A.P.; Last, B.F.; Grootenhuis, M.A. Posttraumatic stress disorder (PTSD) in children after paediatric intensive care treatment compared to children who survived a major fire disaster. Child. Adolesc. Psychiatry Ment. Health 2008, 2, 9. [Google Scholar] [CrossRef] [Green Version]
  9. Lopes-Junior, L.C.; Rosa, M.; Lima, R.A.G. Psychological and Psychiatric Outcomes Following PICU Admission: A Systematic Review of Cohort Studies. Pediatr. Crit. Care Med. 2018, 19, e58–e67. [Google Scholar] [CrossRef]
  10. Fiser, D.H.; Tilford, J.M.; Roberson, P.K. Relationship of illness severity and length of stay to functional outcomes in the pediatric intensive care unit: A multi-institutional study. Crit. Care Med. 2000, 28, 1173–1179. [Google Scholar] [CrossRef]
  11. Bone, M.F.; Feinglass, J.M.; Goodman, D.M. Risk factors for acquiring functional and cognitive disabilities during admission to a PICU*. Pediatr. Crit. Care Med. 2014, 15, 640–648. [Google Scholar] [CrossRef]
  12. Shein, S.L.; Roth, E.; Pace, E.; Slain, K.N.; Wilson-Costello, D. Long-Term Neurodevelopmental and Functional Outcomes of Normally Developing Children Requiring PICU Care for Bronchiolitis. J. Pediatr. Intensive Care 2021, 10, 282–288. [Google Scholar] [CrossRef]
  13. Knoester, H.; Bronner, M.B.; Bos, A.P. Surviving pediatric intensive care: Physical outcome after 3 months. Intensive Care Med. 2008, 34, 1076–1082. [Google Scholar] [CrossRef] [Green Version]
  14. Tang, M.; Xu, M.; Su, S.; Huang, X.; Zhang, S. Post-Intensive Care Syndrome in Children: A Concept Analysis. J. Pediatr. Nurs. 2021, 61, 417–423. [Google Scholar] [CrossRef]
  15. Manning, J.C.; Pinto, N.P.; Rennick, J.E.; Colville, G.; Curley, M.A.Q. Conceptualizing Post Intensive Care Syndrome in Children-The PICS-p Framework. Pediatr. Crit. Care Med. 2018, 19, 298–300. [Google Scholar] [CrossRef]
  16. Herrup, E.A.; Wieczorek, B.; Kudchadkar, S.R. Characteristics of postintensive care syndrome in survivors of pediatric critical illness: A systematic review. World J. Crit. Care Med. 2017, 6, 124–134. [Google Scholar] [CrossRef]
  17. Sobotka, S.A.; Peters, S.; Pinto, N.P. Neurodevelopmental Disorders in the PICU Population. Clin. Pediatr. 2018, 57, 913–919. [Google Scholar] [CrossRef]
  18. Sobotka, S.A.; Agrawal, R.K.; Msall, M.E. Prolonged Hospital Discharge for Children with Technology Dependency: A Source of Health Care Disparities. Pediatr. Ann. 2017, 46, e365–e370. [Google Scholar] [CrossRef]
  19. Choong, K.; Al-Harbi, S.; Siu, K.; Wong, K.; Cheng, J.; Baird, B.; Pogorzelski, D.; Timmons, B.; Gorter, J.W.; Thabane, L.; et al. Functional recovery following critical illness in children: The “wee-cover” pilot study. Pediatr. Crit. Care Med. 2015, 16, 310–318. [Google Scholar] [CrossRef]
  20. Ebrahim, S.; Singh, S.; Hutchison, J.S.; Kulkarni, A.V.; Sananes, R.; Bowman, K.W.; Parshuram, C.S. Adaptive behavior, functional outcomes, and quality of life outcomes of children requiring urgent ICU admission. Pediatr. Crit. Care Med. 2013, 14, 10–18. [Google Scholar] [CrossRef]
  21. Jones, S.; Rantell, K.; Stevens, K.; Colwell, B.; Ratcliffe, J.R.; Holland, P.; Rowan, K.; Parry, G.J.; United Kingdom Pediatric Intensive Care Outcome Study Group. Outcome at 6 months after admission for pediatric intensive care: A report of a national study of pediatric intensive care units in the United kingdom. Pediatrics 2006, 118, 2101–2108. [Google Scholar] [CrossRef]
  22. Knoester, H.; Grootenhuis, M.A.; Bos, A.P. Outcome of paediatric intensive care survivors. Eur. J. Pediatr. 2007, 166, 1119–1128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Fiser, D.H.; Long, N.; Roberson, P.K.; Hefley, G.; Zolten, K.; Brodie-Fowler, M. Relationship of pediatric overall performance category and pediatric cerebral performance category scores at pediatric intensive care unit discharge with outcome measures collected at hospital discharge and 1- and 6-month follow-up assessments. Crit. Care Med. 2000, 28, 2616–2620. [Google Scholar] [CrossRef]
  24. Mohsin, S.S.; Haque, A.; Shaikh, A.S.; Bano, S.; Hasan, B.S. Outcome of infants with unrepaired heart disease admitted to the pediatric intensive care unit: Single-center developing country perspective. Congenit. Heart Dis. 2014, 9, 116–121. [Google Scholar] [CrossRef]
  25. Akhtar, N.; Fadoo, Z.; Panju, S.; Haque, A. Outcome and prognostic factors seen in pediatric oncology patients admitted in PICU of a developing country. Indian J. Pediatr. 2011, 78, 969–972. [Google Scholar] [CrossRef]
  26. Kamal, H.; Mardini, A.; Aly, B.M. Traumatic brain injury in pediatric age group; predictors of outcome in Pediatric Intensive Care Unit. Libyan J. Med. 2007, 2, 90–94. [Google Scholar] [CrossRef]
  27. Farris, R.W.; Weiss, N.S.; Zimmerman, J.J. Functional outcomes in pediatric severe sepsis: Further analysis of the researching severe sepsis and organ dysfunction in children: A global perspective trial. Pediatr. Crit. Care Med. 2013, 14, 835–842. [Google Scholar] [CrossRef] [Green Version]
  28. Maddux, A.B.; Pinto, N.; Fink, E.L.; Hartman, M.E.; Nett, S.; Biagas, K.; Killien, E.Y.; Dervan, L.A.; Christie, L.M.; Luckett, P.M.; et al. Postdischarge Outcome Domains in Pediatric Critical Care and the Instruments Used to Evaluate Them: A Scoping Review. Crit. Care Med. 2020, 48, e1313–e1321. [Google Scholar] [CrossRef]
  29. Needham, D.M.; Sepulveda, K.A.; Dinglas, V.D.; Chessare, C.M.; Friedman, L.A.; Bingham, C.O., 3rd; Turnbull, A.E. Core Outcome Measures for Clinical Research in Acute Respiratory Failure Survivors. An International Modified Delphi Consensus Study. Am. J. Respir. Crit. Care Med. 2017, 196, 1122–1130. [Google Scholar] [CrossRef]
  30. Turnbull, A.E.; Sepulveda, K.A.; Dinglas, V.D.; Chessare, C.M.; Bingham, C.O., 3rd; Needham, D.M. Core Domains for Clinical Research in Acute Respiratory Failure Survivors: An International Modified Delphi Consensus Study. Crit. Care Med. 2017, 45, 1001–1010. [Google Scholar] [CrossRef]
  31. Heneghan, J.A.; Sobotka, S.A.; Hallman, M.; Pinto, N.; Killien, E.Y.; Palumbo, K.; Murphy Salem, S.; Mann, K.; Smith, B.; Steuart, R.; et al. Outcome Measures Following Critical Illness in Children With Disabilities: A Scoping Review. Front. Pediatr. 2021, 9, 689485. [Google Scholar] [CrossRef] [PubMed]
  32. Williamson, P.R.; Altman, D.G.; Blazeby, J.M.; Clarke, M.; Devane, D.; Gargon, E.; Tugwell, P. Developing core outcome sets for clinical trials: Issues to consider. Trials 2012, 13, 132. [Google Scholar] [CrossRef] [Green Version]
  33. Fink, E.L.; Maddux, A.B.; Pinto, N.; Sorenson, S.; Notterman, D.; Dean, J.M.; Carcillo, J.A.; Berg, R.A.; Zuppa, A.; Pollack, M.M.; et al. A Core Outcome Set for Pediatric Critical Care. Crit. Care Med. 2020, 48, 1819–1828. [Google Scholar] [CrossRef]
  34. Topjian, A.A.; Scholefield, B.R.; Pinto, N.P.; Fink, E.L.; Buysse, C.M.P.; Haywood, K.; Maconochie, I.; Nadkarni, V.M.; de Caen, A.; Escalante-Kanashiro, R.; et al. P-COSCA (Pediatric Core Outcome Set for Cardiac Arrest) in Children: An Advisory Statement From the International Liaison Committee on Resuscitation. Circulation 2020, 142, e246–e261. [Google Scholar] [CrossRef]
  35. Kastner, K.; Pinto, N.; Msall, M.E.; Sobotka, S. PICU Follow-Up: The Impact of Missed School in a Cohort of Children Following PICU Admission. Crit. Care Explor. 2019, 1, e0033. [Google Scholar] [CrossRef]
  36. Matics, T.J.; Sanchez-Pinto, L.N. Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children. JAMA Pediatr. 2017, 171, e172352. [Google Scholar] [CrossRef]
  37. Pollack, M.M.; Holubkov, R.; Glass, P.; Dean, J.M.; Meert, K.L.; Zimmerman, J.; Anand, K.J.; Carcillo, J.; Newth, C.J.; Harrison, R.; et al. Functional Status Scale: New pediatric outcome measure. Pediatrics 2009, 124, e18–e28. [Google Scholar] [CrossRef] [Green Version]
  38. Dumas, H.M.; Fragala-Pinkham, M.A.; Rosen, E.L.; O’Brien, J.E. Construct validity of the pediatric evaluation of disability inventory computer adaptive test (PEDI-CAT) in children with medical complexity. Disabil. Rehabil. 2017, 39, 2446–2451. [Google Scholar] [CrossRef]
  39. Varni, J.W.; Seid, M.; Rode, C.A. The PedsQL: Measurement model for the pediatric quality of life inventory. Med. Care 1999, 37, 126–139. [Google Scholar] [CrossRef]
  40. Goodman, R. Psychometric properties of the strengths and difficulties questionnaire. J. Am. Acad. Child. Adolesc. Psychiatry 2001, 40, 1337–1345. [Google Scholar] [CrossRef]
  41. Wolraich, M.L.; Lambert, W.; Doffing, M.A.; Bickman, L.; Simmons, T.; Worley, K. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J. Pediatr. Psychol. 2003, 28, 559–567. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Strickland, B.B.; Jones, J.R.; Newacheck, P.W.; Bethell, C.D.; Blumberg, S.J.; Kogan, M.D. Assessing systems quality in a changing health care environment: The 2009-10 national survey of children with special health care needs. Matern. Child. Health J. 2015, 19, 353–361. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Varni, J.W.; Burwinkle, T.M.; Seid, M.; Skarr, D. The PedsQL 4.0 as a pediatric population health measure: Feasibility, reliability, and validity. Ambul. Pediatr. 2003, 3, 329–341. [Google Scholar] [CrossRef]
  44. Bourdon, K.H.; Goodman, R.; Rae, D.S.; Simpson, G.; Koretz, D.S. The Strengths and Difficulties Questionnaire: U.S. normative data and psychometric properties. J. Am. Acad. Child. Adolesc. Psychiatry 2005, 44, 557–564. [Google Scholar] [CrossRef]
  45. Anderson, N.P.; Feldman, J.A.; Kolko, D.J.; Pilkonis, P.A.; Lindhiem, O. National Norms for the Vanderbilt ADHD Diagnostic Parent Rating Scale in Children. J Pediatr. Psychol. 2022, 47, 652–661. [Google Scholar] [CrossRef] [PubMed]
  46. Harris, P.A.; Taylor, R.; Thielke, R.; Payne, J.; Gonzalez, N.; Conde, J.G. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inf. 2009, 42, 377–381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Pollack, M.M.; Holubkov, R.; Funai, T.; Dean, J.M.; Berger, J.T.; Wessel, D.L.; Meert, K.; Berg, R.A.; Newth, C.J.; Harrison, R.E.; et al. The Pediatric Risk of Mortality Score: Update 2015. Pediatr Crit. Care Med. 2016, 17, 2–9. [Google Scholar] [CrossRef] [Green Version]
  48. Woodruff, A.G.; Choong, K. Long-Term Outcomes and the Post-Intensive Care Syndrome in Critically Ill Children: A North American Perspective. Children 2021, 8, 254. [Google Scholar] [CrossRef]
  49. Gildea, M.R.; Moler, F.W.; Page, K.; Meert, K.; Holubkov, R.; Dean, J.M.; Christensen, J.R.; Slomine, B.S. Methods Used to Maximize Follow-Up: Lessons Learned From the Therapeutic Hypothermia After Pediatric Cardiac Arrest Trials. Pediatr. Crit. Care Med. 2020, 21, 4–11. [Google Scholar] [CrossRef]
  50. Brachio, S.S.; Farkouh-Karoleski, C.; Abreu, A.; Zygmunt, A.; Purugganan, O.; Garey, D. Improving Neonatal Follow-up: A Quality Improvement Study Analyzing In-hospital Interventions and Long-term Show Rates. Pediatr. Qual. Saf. 2020, 5, e363. [Google Scholar] [CrossRef]
  51. Ballantyne, M.; Benzies, K.; Rosenbaum, P.; Lodha, A. Mothers’ and health care providers’ perspectives of the barriers and facilitators to attendance at Canadian neonatal follow-up programs. Child. Care Health Dev. 2015, 41, 722–733. [Google Scholar] [CrossRef] [PubMed]
  52. Ballantyne, M.; Stevens, B.; Guttmann, A.; Willan, A.R.; Rosenbaum, P. Maternal and infant predictors of attendance at Neonatal Follow-Up programmes. Child. Care Health Dev. 2014, 40, 250–258. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Study enrollment.
Figure 1. Study enrollment.
Children 09 01041 g001
Figure 2. Cohort retention and follow-up among PICU survivors. * POP survey = impact survey, functional status scale (FSS), Pediatric Evaluation of Disability Inventory Computer Adaptive Test (PEDI-CAT), Pediatric Quality of Life InventoryTM (PedsQL), Strengths and Difficulties Questionnaire (SDQ), and Vanderbilt Assessment Scales for Attention Deficit-Hyperactivity Disorder (Vanderbilt); PEDI-CAT was not included at 1- and 2-year follow-up.
Figure 2. Cohort retention and follow-up among PICU survivors. * POP survey = impact survey, functional status scale (FSS), Pediatric Evaluation of Disability Inventory Computer Adaptive Test (PEDI-CAT), Pediatric Quality of Life InventoryTM (PedsQL), Strengths and Difficulties Questionnaire (SDQ), and Vanderbilt Assessment Scales for Attention Deficit-Hyperactivity Disorder (Vanderbilt); PEDI-CAT was not included at 1- and 2-year follow-up.
Children 09 01041 g002
Table 1. Demographic and clinical characteristics of study cohort.
Table 1. Demographic and clinical characteristics of study cohort.
CharacteristicEnrollment/Discharge (n = 152)
Age in years, mean (SD)5.2 (5.2)
Sex, n (%)
Male89 (58.6)
Female63 (41.4)
Race, n (%)
Black87 (57.2)
White51 (33.6)
Other14 (9.2)
Ethnicity, n (%)
Hispanic14 (9.2)
Non-Hispanic138 (90.8)
Primary Diagnosis, n (%)
Pulmonary60 (39.5)
Surgical33 (21.7)
Neurologic13 (8.6)
Trauma12 (7.9)
Infection11 (7.2)
Other23 (15.1)
Admission PSOFA, mean (SD) °4.6 (2.4)
Admission PRISM, mean (SD) °9.2 (4.5)
Median length of PICU stay °, days (IQR)3.0 (1.7–8.1)
Median length of Hospital stay °, days (IQR)4 (3–9)
° admission pSOFA and PRISM calculated as maximum scores within 24 h of PICU admission, hospital LOS calculated as full days during hospitalization encounter; PICU stay determined by time of first and last vital-sign recordings.
Table 2. Characteristics of successful follow-up attempts.
Table 2. Characteristics of successful follow-up attempts.
Follow-Up Interval
1 Month
(n = 132)
3 Months
(n = 115)
6 Months
(n = 123)
1 Year
(n = 117)
2 Years
(n = 79)
3 Years
(n = 56)
Number of follow-up attempts, median (IQR)2 (1–4)2 (1–3)2 (1–3)3 (2–6)2 (1–4)4 (3–5)
Day
Weekday completion, n (%)127 (96.2)112 (97.4)115 (93.5)104 (88.9)69 (87.3)48 (85.7)
Weekend completion, n (%)5 (3.8)3 (2.6)8 (6.5)13 (11.1)10 (12.7)8 (14.3)
Time *
Daytime completion, n (%)116 (89.2)99 (91.7)94 (82.4)88 (76.5)57 (72.2)38 (67.9)
Evening completion, n (%)14 (10.8)9 (8.3)20 (17.35)27 (23.5)22 (27.8)18 (32.1)
Days to completion after follow-up eligible, median (IQR)9 (0–34.3)26 (10.5–68)23 (6.5–49)28 (9–65)12 (2–28)38.5 (17.3–124.8)
Completed at later follow-up interval, n (%)19 (14.5)21 (19.3)1 (0.8)N/AN/AN/A
* Time follow-up was not captured for a minority of patients (<10% at all intervals).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sobotka, S.A.; Lynch, E.J.; Dholakia, A.V.; Mayampurath, A.; Pinto, N.P. PICU Survivorship: Factors Affecting Feasibility and Cohort Retention in a Long-Term Outcomes Study. Children 2022, 9, 1041. https://0-doi-org.brum.beds.ac.uk/10.3390/children9071041

AMA Style

Sobotka SA, Lynch EJ, Dholakia AV, Mayampurath A, Pinto NP. PICU Survivorship: Factors Affecting Feasibility and Cohort Retention in a Long-Term Outcomes Study. Children. 2022; 9(7):1041. https://0-doi-org.brum.beds.ac.uk/10.3390/children9071041

Chicago/Turabian Style

Sobotka, Sarah A., Emma J. Lynch, Ayesha V. Dholakia, Anoop Mayampurath, and Neethi P. Pinto. 2022. "PICU Survivorship: Factors Affecting Feasibility and Cohort Retention in a Long-Term Outcomes Study" Children 9, no. 7: 1041. https://0-doi-org.brum.beds.ac.uk/10.3390/children9071041

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop